Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
American Journal of Human Genetics|September 20, 2016
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 RegulationMaya Ghoussaini, Juliet D French, Kyriaki Michailidou, et al.
Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.
Journal of Medical Genetics|February 28, 2016
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testingDouglas F Easton, Fabienne Lesueur, Brennan Decker, et al.
Cancer Research|November 26, 2013
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Bridget Charbonneau, Matthew S Block, William R Bamlet, et al.
Human Molecular Genetics|September 15, 2012
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11Afshan Siddiq, Fergus J Couch, Gary K Chen, et al.
Nature Communications|March 29, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerHui Shen, Brooke L Fridley, Honglin Song, et al.
Human Molecular Genetics|June 20, 2014
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumRoger L Milne, Barbara Burwinkel, Kyriaki Michailidou, et al.
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Pageof 18